Outcomes of 23-Gauge Vitrectomy Combined with Phacoemulsification, Panretinal Photocoagulation, and Trabeculectomy without Use of Anti-VEGF Agents for Neovascular Glaucoma with Vitreous Hemorrhage
Table 1
Clinical data of patients with NVG.
Case number
Sex
Age (y)
Systemic disease
Diagnosis
Previous treatment
BCVA
IOP (mmHg)
Complications
Follow-up (months)
Preop.
Postop.
Preop.
Postop.
1
M
76
Hypertension
CRVO
B + C
0.02
0.08
58
21
Fibrosis exudates in AC
16
2
M
61
DM + hypertension
CRVO
B + C, partial laser
0.04
0.04
53
22
None
17
3
F
58
DM + RF
PDR + BRVO
B + C
LP
0.02
60
30
Fibrosis exudates in AC
12
4
F
62
DM + hypertension
CRVO
B + C, partial laser
HM
0.04
58
20
None
15
5
M
59
DM + RF
PDR + BRVO
B + C
CF
0.04
59
18
Temporary IOP elevation
14
6
F
61
DM + RF
PDR
B + C
0.08
0.1
48
17
None
17
7
M
63
DM + hypertension
CRVO
B + C
0.06
0.1
61
19
Fibrosis exudates in AC
12
8
M
63
DM + RF
PDR
B + C, partial laser
0.1
0.3
40
15
Fibrosis exudates in AC
13
9
F
59
DM + RF
PDR + BRVO
B + C
0.08
0.08
39
16
None
12
10
M
58
DM + hypertension
CRVO
B + C, partial laser
0.04
0.06
56
21
Fibrosis exudates in AC
12
11
F
60
DM + hypertension
PDR + BRVO
B + C
HM
0.02
58
19
SCH
24
12
F
63
DM + hypertension
PDR + BRVO
B + C
HM
0.08
57
18
None
13
13
M
59
DM + RF
PDR
B + C, partial laser
0.02
0.02
56
20
Fibrosis exudates in AC
17
14
M
71
Hypertension
CRVO
B + C
0.02
0.04
54
18
Fibrosis exudates in AC
12
15
F
63
DM + RF
PDR + BRVO
B + C
LP
0.04
64
19
Temporary IOP elevation
16
16
M
58
DM + hypertension
CRVO
B + C
CF
0.06
55
17
None
14
17
M
63
DM + RF
PDR
B + C
0.04
0.04
54
18
None
13
18
F
65
Hypertension
CRVO
B + C, partial laser
0.2
0.4
38
10
None
13
F = female; M = male; DM = diabetes mellitus; RF = renal failure; BCVA = best corrected visual acuity; AC = anterior chamber; SCH = suprachoroidal hemorrhage; B = brinzolamide; C = 2% carteolol hydrochloride.